Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4276979 | Urology Practice | 2015 | 7 Pages |
Abstract
During 2008 to 2013 mitomycin C was not used in a significant proportion of patients who underwent transurethral resection of the bladder. The implementation of a revised protocol governing mitomycin C use significantly and positively impacted mitomycin C use. Importantly, pharmacy shortages no longer contribute to the nonuse of mitomycin C in patients with bladder cancer. These data highlight the impact of continual improvement initiatives on standard clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Joseph Cusano, Peter Haddock, Max Jackson, Matthew Luk, Scott Wiener, Ashley Cox, Anoop Meraney,